Johnson Investment Counsel Inc. Purchases 2,550 Shares of Intuitive Surgical, Inc. $ISRG

Johnson Investment Counsel Inc. lifted its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 8.8% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 31,592 shares of the medical equipment provider’s stock after acquiring an additional 2,550 shares during the quarter. Johnson Investment Counsel Inc.’s holdings in Intuitive Surgical were worth $14,129,000 at the end of the most recent reporting period.

Other large investors have also recently made changes to their positions in the company. Tobam lifted its stake in Intuitive Surgical by 666.7% in the second quarter. Tobam now owns 46 shares of the medical equipment provider’s stock worth $25,000 after purchasing an additional 40 shares during the last quarter. Kilter Group LLC purchased a new stake in shares of Intuitive Surgical in the second quarter worth approximately $27,000. Greykasell Wealth Strategies Inc. purchased a new stake in shares of Intuitive Surgical in the third quarter worth approximately $27,000. Princeton Global Asset Management LLC bought a new stake in shares of Intuitive Surgical during the 2nd quarter worth approximately $30,000. Finally, Guerra Advisors Inc purchased a new position in Intuitive Surgical during the 3rd quarter valued at $37,000. 83.64% of the stock is owned by hedge funds and other institutional investors.

Insider Activity

In other Intuitive Surgical news, Director Gary S. Guthart sold 2,800 shares of the business’s stock in a transaction dated Tuesday, January 27th. The shares were sold at an average price of $531.52, for a total value of $1,488,256.00. Following the completion of the transaction, the director directly owned 15,720 shares in the company, valued at approximately $8,355,494.40. The trade was a 15.12% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, Director Craig H. Barratt sold 750 shares of the stock in a transaction dated Wednesday, November 12th. The shares were sold at an average price of $580.00, for a total transaction of $435,000.00. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 70,011 shares of company stock worth $38,858,275 over the last ninety days. 0.70% of the stock is currently owned by corporate insiders.

Intuitive Surgical Stock Performance

Shares of ISRG opened at $492.84 on Tuesday. The stock has a market capitalization of $175.02 billion, a PE ratio of 62.46, a PEG ratio of 3.79 and a beta of 1.65. The company has a 50 day moving average price of $548.13 and a 200-day moving average price of $510.63. Intuitive Surgical, Inc. has a fifty-two week low of $425.00 and a fifty-two week high of $609.08.

Intuitive Surgical (NASDAQ:ISRG) last posted its earnings results on Thursday, January 22nd. The medical equipment provider reported $2.53 earnings per share for the quarter, topping analysts’ consensus estimates of $2.27 by $0.26. The company had revenue of $2.87 billion during the quarter, compared to analyst estimates of $2.72 billion. Intuitive Surgical had a return on equity of 15.06% and a net margin of 28.38%.Intuitive Surgical’s revenue was up 18.8% on a year-over-year basis. During the same quarter in the prior year, the business earned $2.21 earnings per share. Equities research analysts forecast that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Wall Street Analyst Weigh In

A number of research firms have weighed in on ISRG. Mizuho set a $575.00 target price on Intuitive Surgical in a research note on Wednesday, October 22nd. Robert W. Baird cut their price target on shares of Intuitive Surgical from $655.00 to $645.00 and set an “outperform” rating on the stock in a report on Friday, January 23rd. Jefferies Financial Group lifted their price objective on shares of Intuitive Surgical from $550.00 to $560.00 and gave the company a “hold” rating in a report on Wednesday, October 22nd. Argus lowered their price objective on shares of Intuitive Surgical from $630.00 to $560.00 and set a “buy” rating for the company in a research report on Wednesday, February 4th. Finally, Wells Fargo & Company raised their target price on shares of Intuitive Surgical from $600.00 to $654.00 and gave the stock an “overweight” rating in a research report on Friday, December 12th. One investment analyst has rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating, eight have assigned a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat, Intuitive Surgical has a consensus rating of “Moderate Buy” and an average target price of $617.23.

Intuitive Surgical Company Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.